NCT04584424View on ClinicalTrials.gov

Prognostic Factors and Outcomes of COVID-19 Cases in Ethiopia

CompletedOBSERVATIONAL
Enrollment

6,390

Participants

Timeline

Start Date

October 30, 2020

Primary Completion Date

November 14, 2022

Study Completion Date

November 14, 2022

Conditions
EpidemiologyClinicalNutritional-statusImmunologic Defect
Interventions
OTHER

The study does not required

The study is prospective multi-center COVID-19 patient cohort

Trial Locations (1)

1242

Saro Abdella, Addis Ababa

All Listed Sponsors
lead

Ethiopian Public Health Institute

OTHER_GOV

NCT04584424 - Prognostic Factors and Outcomes of COVID-19 Cases in Ethiopia | Biotech Hunter | Biotech Hunter